1. Home
  2. RBBN vs DCTH Comparison

RBBN vs DCTH Comparison

Compare RBBN & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ribbon Communications Inc.

RBBN

Ribbon Communications Inc.

HOLD

Current Price

$2.01

Market Cap

355.8M

Sector

Technology

ML Signal

HOLD

Logo Delcath Systems Inc.

DCTH

Delcath Systems Inc.

HOLD

Current Price

$12.22

Market Cap

372.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RBBN
DCTH
Founded
1997
1988
Country
United States
United States
Employees
3080
N/A
Industry
EDP Services
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
355.8M
372.5M
IPO Year
2017
2015

Fundamental Metrics

Financial Performance
Metric
RBBN
DCTH
Price
$2.01
$12.22
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
4
Target Price
$4.67
$22.00
AVG Volume (30 Days)
784.5K
379.0K
Earning Date
04-28-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
170.97
107.53
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$1.97
$24.54
Revenue Next Year
$6.69
$33.15
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.83
$8.12
52 Week High
$4.24
$13.74

Technical Indicators

Market Signals
Indicator
RBBN
DCTH
Relative Strength Index (RSI) 37.02 44.31
Support Level $1.83 $9.98
Resistance Level $2.86 $12.48
Average True Range (ATR) 0.14 0.51
MACD -0.00 -0.17
Stochastic Oscillator 5.49 1.71

Price Performance

Historical Comparison
RBBN
DCTH

About RBBN Ribbon Communications Inc.

Ribbon Communications Inc provides communications technology to service providers and enterprises, offering software and high-performance hardware products, network solutions, and services for secure data and voice communications, as well as high-bandwidth networking for residential and enterprise customers across industries such as finance, education, government, utilities, and transportation. It operates through two segments: Cloud and Edge, which generate maximum revenue and deliver software-centric, cloud-native solutions for VoIP, VoLTE, VoNR, and unified communications, and IP Optical Networks, which support growing telecommunications traffic from 5G, distributed cloud computing, and other applications. The Company generates the majority of its revenue from the United States.

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. The company is focused on the treatment of primary and metastatic liver cancers. The firm's product include Melphalan Hydrochloride, Hepzato for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Share on Social Networks: